Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Market Cap 86Cr 17Cr 14Cr 13Cr 12Cr 23Cr 1.58TCr 23Cr 158.31Cr 62Cr 791.86Cr 62Cr 61Cr 2.64TCr P/E 2024
6.95x
P/E 2025 9.42x
Enterprise Value 202.37Cr 39Cr 34Cr 32Cr 29Cr 54Cr 3.73TCr 55Cr 373.8Cr 146.12Cr 1.87TCr 147Cr 143.8Cr 6.23TCr EV / Sales 2024
0.18x
EV / Sales 2025 0.2x
Free-Float
32.86%
Yield 2024
8.86%
Yield 2025 -
30/07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07/05 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
16/03 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
03/03 Brazil's Profarma to buy 4Bio from Raia Drogasil in 600 mln reais deal RE
05/11 Bmk, Bpl negotiate potential acquisition of Bpl shares in Brazil's Profarma RE
30/25/30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
31/25/31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
05/25/05 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
19/25/19 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
19/25/19 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
31/24/31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
07/24/07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
08/24/08 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
1 day+3.10%
1 week-1.41%
Current month+1.01%
1 month+1.30%
3 months-0.99%
6 months-17.57%
Current year-23.44%
1 week 6.66
Extreme 6.66
7.18
1 month 6.11
Extreme 6.11
7.21
Current year 6.11
Extreme 6.11
9.7
1 year 6.11
Extreme 6.11
9.7
3 years 3.4
Extreme 3.4
9.7
5 years 2.92
Extreme 2.92
9.7
10 years 2.87
Extreme 2.87
11.79
Manager TitleAgeSince
Chief Executive Officer 57 21/04/2010
Director of Finance/CFO 68 01/01/1993
Director TitleAgeSince
Chairman 57 03/04/2008
Director/Board Member 91 21/04/2010
Director/Board Member 62 21/04/2010
Date Insider Type Main position Quantity % Market Cap.
08/08/25 Others 1 0.0000%
09/12/24 Sell 12,200 0.0099%
09/12/24 Sell 12,400 0.0100%
Change 5-day change 1-year change 3-year change Capi.($)
+3.10%-1.41%-9.69%+67.63% 17Cr
-2.55%+0.17%+33.34%+99.68% 10TCr
-2.54%-2.12%+60.05%+153.47% 5.45TCr
+0.68%-0.67%+3.85%+268.94% 2.41TCr
-0.78%+0.61%-12.93%-14.11% 822.79Cr
-1.04%+5.66%-30.42%-25.18% 767.16Cr
+0.42%-1.64%-12.98%-21.22% 666.09Cr
+0.48%+0.43%+18.27%+16.29% 618.6Cr
-1.41%-4.96%-5.85%+19.81% 493.78Cr
-0.59%+2.65%-5.97%-4.99% 372.67Cr
Average -0.46%-0.29%+3.77%+56.03% 2.19TCr
Weighted average by Cap. -1.87%-0.44%+29.34%+113.42%

Financials

2024 2025
Net sales 1.02TCr 196.44Cr 170.19Cr 159.46Cr 145.45Cr 273.44Cr 19TCr 277.64Cr 1.88TCr 733.12Cr 9.38TCr 737.54Cr 721.51Cr 31TCr 1.15TCr 221.53Cr 191.93Cr 179.83Cr 164.02Cr 308.37Cr 21TCr 313.11Cr 2.12TCr 826.76Cr 11TCr 831.75Cr 813.67Cr 35TCr
Net income 11Cr 2.22Cr 1.92Cr 1.8Cr 1.64Cr 3.09Cr 211.43Cr 3.13Cr 21Cr 8.27Cr 105.86Cr 8.32Cr 8.14Cr 353Cr 12Cr 2.3Cr 1.99Cr 1.87Cr 1.7Cr 3.2Cr 219.4Cr 3.25Cr 22Cr 8.58Cr 109.85Cr 8.64Cr 8.45Cr 366.31Cr
Net Debt 101.72Cr 20Cr 17Cr 16Cr 15Cr 27Cr 1.88TCr 28Cr 187.88Cr 73Cr 939.79Cr 74Cr 72Cr 3.13TCr 116.67Cr 23Cr 20Cr 18Cr 17Cr 31Cr 2.15TCr 32Cr 215.5Cr 84Cr 1.08TCr 85Cr 83Cr 3.59TCr
Logo Profarma Distribuidora de Produtos Farmacêuticos S.A.
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Employees
7,077
Date Price Change Volume
12/26/12 R$6.990 -0.14% 1,05,300
11/26/11 R$7.000 -0.14% 2,18,100
10/26/10 R$7.010 -0.57% 1,31,100
07/26/07 R$7.050 +0.43% 93,500
06/26/06 R$7.020 -0.99% 2,09,500
  1. Stock Market
  2. Stocks
  3. PFRM3 Stock